This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw JSON (canonical form + also see JSON Format Specification)
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped
{ "resourceType": "MedicationDispense", "id": "meddisp0317", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: stopped</p><h3>Medications</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table><p><b>subject</b>: <a>Donald Duck . Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a></p><h3>Performers</h3><table><tr><td>-</td><td><b>Actor</b></td></tr><tr><td>*</td><td><a>Generated Summary: id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); Phone: 0205569288, R.A.vandenberk@bmc.nl, Fax: 0205664987; gender: male; birthDate: 1975-12-07</a></td></tr></table><p><b>authorizingPrescription</b>: <a>Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphoma-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a></p><p><b>type</b>: <span>Trial Fill</span></p><p><b>quantity</b>: 3 415818005</p><p><b>daysSupply</b>: 1 Day</p><p><b>whenPrepared</b>: 25 Jun. 2015, 12:13:00 pm</p><p><b>whenHandedOver</b>: 26 Jun. 2015, 12:13:00 pm</p><h3>DosageInstructions</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></div>" }, "contained": [ { "resourceType": "Medication", "id": "med0306", "code": { "coding": [ { "system": "http://hl7.org/fhir/sid/ndc", "code": "51144-050-01", "display": "Adcetris (Brentuximab Vedotin 50mg/10.5ml)" } ] }, "sponsor": { "reference": "Organization/mmanu" }, "doseForm": { "coding": [ { "system": "http://snomed.info/sct", "code": "421637006", "display": "Lyophilized powder for injectable solution (qualifier value) " } ] } } ], "status": "stopped", "medication": { "reference": { "reference": "#med0306", "display": "Brentixumab Vedotin (Adcetris)" } }, "subject": { "reference": "Patient/pat1", "display": "Donald Duck " }, "performer": [ { "actor": { "reference": "Practitioner/f006" } } ], "authorizingPrescription": [ { "reference": "MedicationRequest/medrx0316" } ], "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActCode", "code": "TF", "display": "Trial Fill" } ] }, "quantity": { "value": 3, "system": "http://snomed.info/sct", "code": "415818005" }, "daysSupply": { "value": 1, "unit": "Day", "system": "http://unitsofmeasure.org", "code": "d" }, "whenPrepared": "2015-06-25T07:13:00+05:00", "whenHandedOver": "2015-06-26T07:13:00+05:00", "dosageInstruction": [ { "sequence": 1, "text": "1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles", "timing": { "repeat": { "count": 16, "frequency": 1, "period": 3, "periodUnit": "wk" } }, "route": { "coding": [ { "system": "http://snomed.info/sct", "code": "255560000", "display": "Intravenous" } ] }, "doseAndRate": [ { "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/dose-rate-type", "code": "ordered", "display": "Ordered" } ] }, "doseQuantity": { "value": 1.8, "unit": "mg/kg", "system": "http://unitsofmeasure.org", "code": "mg/kg" } } ] } ] }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.